Fermion, Simcere

Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Guangzhou Fermion Technology Co., Ltd. Simcere Pharmaceutical Group Limited China

View original content:https://www.prnewswire.co.uk/news-releases/fermion-and-simcere-enter-into-an-exclusive-license-and-collaboration-agreement-for-chinas-first-sstr4-agonist-targeting-pain-302354671.html

en | boerse | 67949427 |